PT2516435E - Inibidores da actividade de akt - Google Patents
Inibidores da actividade de akt Download PDFInfo
- Publication number
- PT2516435E PT2516435E PT108009804T PT10800980T PT2516435E PT 2516435 E PT2516435 E PT 2516435E PT 108009804 T PT108009804 T PT 108009804T PT 10800980 T PT10800980 T PT 10800980T PT 2516435 E PT2516435 E PT 2516435E
- Authority
- PT
- Portugal
- Prior art keywords
- inhibitors
- akt activity
- akt
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0922589.7A GB0922589D0 (en) | 2009-12-23 | 2009-12-23 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2516435E true PT2516435E (pt) | 2014-11-13 |
Family
ID=41716932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT108009804T PT2516435E (pt) | 2009-12-23 | 2010-12-23 | Inibidores da actividade de akt |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9221838B2 (pt) |
| EP (1) | EP2516435B8 (pt) |
| JP (1) | JP5923043B2 (pt) |
| KR (1) | KR20140015157A (pt) |
| CN (1) | CN102791708B (pt) |
| AU (1) | AU2010334591C1 (pt) |
| BR (1) | BR112012015677A2 (pt) |
| CA (1) | CA2783340C (pt) |
| CY (1) | CY1115686T1 (pt) |
| DK (1) | DK2516435T3 (pt) |
| ES (1) | ES2503794T3 (pt) |
| GB (1) | GB0922589D0 (pt) |
| HK (1) | HK1171013A1 (pt) |
| IL (1) | IL220153A (pt) |
| MX (1) | MX2012007274A (pt) |
| NZ (1) | NZ600453A (pt) |
| PL (1) | PL2516435T3 (pt) |
| PT (1) | PT2516435E (pt) |
| RU (1) | RU2579513C2 (pt) |
| SG (1) | SG181517A1 (pt) |
| SI (1) | SI2516435T1 (pt) |
| WO (1) | WO2011077098A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201205164D0 (en) | 2012-03-23 | 2012-05-09 | Almac Discovery Ltd | Pharmaceutical compounds |
| CA2971763A1 (en) * | 2014-12-23 | 2016-06-30 | Bergenbio Asa | Inhibitors of akt kinase |
| US10323044B2 (en) * | 2015-02-27 | 2019-06-18 | Taiho Pharmaceutical Co., Ltd. | Crystal of imidazo-oxazine, pharmaceutical composition containing said crystal, and method for producing said crystal |
| GB201603779D0 (en) | 2016-03-04 | 2016-04-20 | Mission Therapeutics Ltd | Novel compounds |
| US11208478B2 (en) | 2016-08-07 | 2021-12-28 | The Wistar Institute Of Anatomy And Biology | Methods of detecting and treating a tumor expressing pT346 PDK1 |
| UA125730C2 (uk) * | 2017-06-22 | 2022-05-25 | Курадев Фарма Лімітед | Низькомолекулярні модулятори sting людини |
| JP2020533317A (ja) | 2017-09-07 | 2020-11-19 | オーガスタ ユニバーシティ リサーチ インスティテュート，インコーポレーテッド | 特異的ａｋｔ３活性化剤およびその使用 |
| GB2600384A (en) | 2020-09-30 | 2022-05-04 | Vaderis Therapeutics Ag | Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1085666C (zh) * | 1994-11-14 | 2002-05-29 | 沃尼尔·朗伯公司 | 用于抑制蛋白质酪氨酸激酶介导的细胞增殖的6－芳基吡啶并[2,3－d]嘧啶和1,5－二氮杂萘 |
| TWI301760B (en) * | 2004-02-27 | 2008-10-11 | Merz Pharma Gmbh & Co Kgaa | Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| US7910561B2 (en) * | 2004-12-15 | 2011-03-22 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
| US8008317B2 (en) * | 2005-06-10 | 2011-08-30 | Merck Sharp & Dohme Corp. | Inhibitors of akt activtiy |
| WO2008011032A1 (en) * | 2006-07-17 | 2008-01-24 | Amgen Inc. | Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| US20100022573A1 (en) | 2006-12-06 | 2010-01-28 | Layton Mark E | Inhibitors of akt activity |
| AR064010A1 (es) | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| US7999107B2 (en) * | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| CA2726358A1 (en) | 2008-06-03 | 2009-12-10 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| JP2011522048A (ja) * | 2008-06-03 | 2011-07-28 | メルク・シャープ・エンド・ドーム・コーポレイション | Ａｋｔ活性の阻害剤 |
-
2009
- 2009-12-23 GB GBGB0922589.7A patent/GB0922589D0/en not_active Ceased
-
2010
- 2010-12-23 MX MX2012007274A patent/MX2012007274A/es active IP Right Grant
- 2010-12-23 CA CA2783340A patent/CA2783340C/en not_active Expired - Fee Related
- 2010-12-23 AU AU2010334591A patent/AU2010334591C1/en not_active Ceased
- 2010-12-23 BR BRBR112012015677-2A patent/BR112012015677A2/pt not_active Application Discontinuation
- 2010-12-23 DK DK10800980.4T patent/DK2516435T3/da active
- 2010-12-23 JP JP2012545434A patent/JP5923043B2/ja active Active
- 2010-12-23 PT PT108009804T patent/PT2516435E/pt unknown
- 2010-12-23 KR KR1020127019033A patent/KR20140015157A/ko not_active Application Discontinuation
- 2010-12-23 EP EP10800980.4A patent/EP2516435B8/en active Active
- 2010-12-23 PL PL10800980T patent/PL2516435T3/pl unknown
- 2010-12-23 NZ NZ600453A patent/NZ600453A/xx not_active IP Right Cessation
- 2010-12-23 SG SG2012041232A patent/SG181517A1/en unknown
- 2010-12-23 RU RU2012131115/04A patent/RU2579513C2/ru not_active IP Right Cessation
- 2010-12-23 SI SI201030774T patent/SI2516435T1/sl unknown
- 2010-12-23 CN CN201080059321.9A patent/CN102791708B/zh active Active
- 2010-12-23 WO PCT/GB2010/002329 patent/WO2011077098A1/en active Application Filing
- 2010-12-23 US US13/517,219 patent/US9221838B2/en active Active
- 2010-12-23 ES ES10800980.4T patent/ES2503794T3/es active Active
-
2012
- 2012-06-04 IL IL220153A patent/IL220153A/en not_active IP Right Cessation
- 2012-11-16 HK HK12111698.8A patent/HK1171013A1/xx not_active IP Right Cessation
-
2014
- 2014-10-31 CY CY20141100899T patent/CY1115686T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013515710A (ja) | 2013-05-09 |
| ES2503794T3 (es) | 2014-10-07 |
| CN102791708B (zh) | 2016-03-02 |
| RU2579513C2 (ru) | 2016-04-10 |
| EP2516435A1 (en) | 2012-10-31 |
| CA2783340C (en) | 2015-11-24 |
| EP2516435B8 (en) | 2014-10-15 |
| NZ600453A (en) | 2013-10-25 |
| GB0922589D0 (en) | 2010-02-10 |
| BR112012015677A2 (pt) | 2015-06-30 |
| HK1171013A1 (en) | 2013-03-15 |
| CN102791708A (zh) | 2012-11-21 |
| AU2010334591C1 (en) | 2014-07-31 |
| AU2010334591B2 (en) | 2014-04-10 |
| EP2516435B1 (en) | 2014-08-06 |
| AU2010334591A1 (en) | 2012-06-21 |
| KR20140015157A (ko) | 2014-02-06 |
| IL220153A (en) | 2015-05-31 |
| WO2011077098A9 (en) | 2012-04-19 |
| US20130116243A1 (en) | 2013-05-09 |
| MX2012007274A (es) | 2012-10-03 |
| CY1115686T1 (el) | 2017-01-25 |
| US9221838B2 (en) | 2015-12-29 |
| SI2516435T1 (sl) | 2014-12-31 |
| WO2011077098A1 (en) | 2011-06-30 |
| CA2783340A1 (en) | 2011-06-30 |
| RU2012131115A (ru) | 2014-01-27 |
| JP5923043B2 (ja) | 2016-05-24 |
| DK2516435T3 (da) | 2014-10-13 |
| SG181517A1 (en) | 2012-07-30 |
| IL220153A0 (en) | 2012-07-31 |
| PL2516435T3 (pl) | 2015-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2391623A4 (en) | INHIBITORS OF AKT ACTIVITY | |
| EP2413932A4 (en) | INHIBITORS OF AKT ACTIVITY | |
| EP2303269A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2406250A4 (en) | HAMMER OF ACT ACTIVITY | |
| ZA201700326B (en) | Inhibitors of beta-secretase | |
| HK1132676A1 (en) | Inhibitors of akt activity akt | |
| IL209488A0 (en) | Inhibitors of akt activity | |
| EP2114388A4 (en) | INHIBITORS OF AKT'S ACTIVITY | |
| HK1159102A1 (en) | Inhibitors of ssao activity ssao | |
| HK1137758A1 (en) | Inhibitors of akt activity akt | |
| HK1171390A1 (en) | Heparanase activity inhibitor | |
| EP2405756A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2306825A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303852A4 (en) | ACTIVITY INHIBITORS AKT | |
| HK1171013A1 (en) | Inhibitors of akt activity akt | |
| EP2134175A4 (en) | HAMMER OF ACT ACTIVITY | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| HK1171624A1 (en) | Inhibitors of cognitive decline | |
| HK1167323A1 (en) | Inhibitors of cognitive decline | |
| EP2120951A4 (en) | INHIBITORS OF AKT ACTIVITY | |
| EP2579872A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303277A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303017A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303258A4 (en) | ACTIVITY INHIBITORS AKT | |
| EP2513059A4 (en) | HAMMER OF ACT ACTIVITY |